CN Stock MarketDetailed Quotes
600062 China Resources Double-Crane Pharmaceutical
- 18.24
- +0.48+2.70%
Not Open Jul 26 15:00 CST
18.96BMarket Cap13.80P/E (TTM)
18.27High17.75Low99.17KlotVolume17.83Open17.76Pre Close179.23MTurnover0.97%Turnover Ratio14.23P/E (Static)1.04BShares23.8752wk High1.69P/B18.73BFloat Cap14.5452wk Low19.54Limit Up1.03BShs Float36.13Historical High15.98Limit Down2.93%Amplitude-1.75Historical Low0.26Dividend TTM18.07Avg Price50.35KlotAsk1.41%Div YieldTTM100Lot Size47.88KlotBid
China Resources Double-Crane Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 1.23%2.46B | 5.61%9.83B | 8.92%7.23B | 9.31%4.97B | 10.79%2.43B | 1.32%9.31B | -3.25%6.64B | -1.77%4.54B | -6.48%2.19B | 9.55%9.19B |
| Refunds of taxes and levies | -79.46%3.57M | -9.75%70.66M | 39.00%65.52M | 95.75%64.16M | -21.61%17.38M | 7.70%78.3M | -20.93%47.14M | -27.69%32.78M | -22.69%22.17M | 3,115.17%72.7M |
| Cash received relating to other operating activities | 93.76%22.56M | -30.16%119.38M | -24.60%93.18M | -31.04%54.31M | -63.61%11.64M | -16.03%170.93M | -41.11%123.58M | 9.56%78.77M | 17.61%32M | 123.48%203.55M |
| Cash inflows from operating activities | 1.09%2.48B | 4.85%10.02B | 8.52%7.39B | 9.24%5.09B | 9.41%2.46B | 0.99%9.56B | -4.51%6.81B | -1.84%4.66B | -6.40%2.25B | 11.60%9.47B |
| Goods services cash paid | -22.05%452.05M | -18.63%1.98B | -11.62%1.57B | -5.91%1.17B | -2.99%579.93M | -2.10%2.44B | -5.47%1.78B | -2.76%1.25B | -3.71%597.83M | 49.36%2.49B |
| Staff behalf paid | 7.19%715.98M | 10.15%2.15B | 13.44%1.63B | 16.72%1.14B | 13.75%667.93M | 6.98%1.95B | 3.18%1.44B | 1.11%976.49M | 2.96%587.21M | 10.66%1.82B |
| All taxes paid | 14.41%348.02M | 21.93%1.18B | 28.26%863.07M | 28.14%604.9M | 25.10%304.19M | 0.56%965.67M | -9.76%672.93M | -9.91%472.05M | -10.58%243.16M | -1.41%960.31M |
| Cash paid relating to other operating activities | -15.10%666.01M | 10.48%3.09B | 11.32%2.29B | 17.28%1.52B | 23.00%784.46M | -2.16%2.79B | -4.98%2.06B | -0.50%1.29B | 4.00%637.75M | 0.69%2.85B |
| Cash outflows from operating activities | -6.61%2.18B | 3.06%8.39B | 6.89%6.36B | 11.19%4.43B | 13.10%2.34B | 0.23%8.14B | -3.87%5.95B | -2.04%3.99B | -0.50%2.07B | 14.09%8.13B |
| Net cash flows from operating activities | 150.61%301.69M | 15.15%1.63B | 19.73%1.03B | -2.40%651.97M | -32.98%120.39M | 5.61%1.42B | -8.76%860.48M | -0.63%668.02M | -44.34%179.64M | -1.41%1.34B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 19.65%240.3M | -19.39%2.3B | -17.09%1.7B | -55.06%651.92M | -69.10%200.84M | -5.48%2.86B | 4.12%2.05B | 5.69%1.45B | -20.98%650M | 33.49%3.02B |
| Cash received from returns on investments | -12.00%1.46M | -77.48%21.35M | -57.39%18.09M | -35.94%5.33M | -59.46%1.66M | 224.59%94.81M | 167.46%42.45M | -14.38%8.32M | -16.31%4.09M | -8.19%29.21M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1,785.31%1.73M | -24.56%2.95M | -71.44%921.13K | -90.15%274.79K | -50.63%91.87K | -65.72%3.91M | -69.84%3.23M | -58.61%2.79M | -89.42%186.09K | -73.25%11.41M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --36.59M |
| Cash received relating to other investing activities | ---- | 1,098.38%60.95M | ---- | ---- | ---- | -76.90%5.09M | -74.47%5.09M | -76.56%4.18M | -94.96%2.09M | 71.13%22.01M |
| Cash inflows from investing activities | 20.19%243.49M | -19.34%2.39B | -18.18%1.72B | -55.15%657.52M | -69.14%202.59M | -5.16%2.96B | 4.24%2.1B | 4.20%1.47B | -24.61%656.37M | 32.76%3.12B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 7.46%98.54M | 14.79%604.47M | -4.84%362.76M | -16.63%221.69M | -38.62%91.69M | 7.10%526.6M | 69.07%381.22M | 88.42%265.91M | 143.82%149.38M | 41.25%491.67M |
| Cash paid to acquire investments | -81.82%100M | 73.33%2.34B | 78.26%2.05B | 86.67%1.4B | -15.38%550M | -57.81%1.35B | -50.00%1.15B | -51.60%750M | -27.75%650M | 32.15%3.2B |
| Net cash paid to acquire subsidiaries and other business units | ---- | -68.19%130.18M | ---- | ---- | ---- | --409.22M | --562.81M | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | --82.62M | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -69.06%198.54M | 29.82%3.07B | 15.22%2.41B | 59.63%1.62B | -19.73%641.69M | -35.84%2.37B | -17.08%2.09B | -39.91%1.02B | -16.81%799.38M | 33.29%3.69B |
| Net cash flows from investing activities | 110.24%44.95M | -215.89%-686.42M | -6,642.43%-690.86M | -314.24%-964.17M | -207.03%-439.11M | 203.94%592.28M | 102.09%10.56M | 258.52%450.05M | -58.50%-143.02M | -36.32%-569.8M |
| Financing cash flow | ||||||||||
| Cash from borrowing | ---- | 935.54%15M | ---- | ---- | ---- | -69.47%1.45M | -37.84%1.45M | --1.45M | --1.45M | --4.75M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | --144.72M | --132.75M | --132.75M | --132.75M | ---- |
| Cash inflows from financing activities | ---- | -89.74%15M | ---- | ---- | ---- | 2,980.55%146.17M | 5,659.00%134.2M | --134.2M | --134.2M | --4.75M |
| Borrowing repayment | --2.26M | 10.21%6.83M | -20.14%4.95M | -42.46%3.56M | ---- | --6.19M | --6.19M | --6.19M | ---- | ---- |
| Dividend interest payment | 34.17%1.68M | -58.70%333.26M | -59.89%130.16M | -95.41%9.14M | 2,309.48%1.25M | 160.98%807M | 4.96%324.51M | 3,601.42%199.03M | --51.96K | -3.20%309.22M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | 422.74%27.37M | 24.94%6.41M | --6.41M | ---- | -21.06%5.24M | --5.13M | ---- | ---- | 6,122.13%6.63M |
| Cash payments relating to other financing activities | -33.55%8.34M | -94.46%34.59M | -91.63%25.11M | -94.33%16.63M | -95.63%12.55M | 741.82%624.16M | 340.84%300.14M | 378.38%293.45M | 8,598.74%287.46M | 2,938.06%74.14M |
| Cash outflows from financing activities | -11.00%12.28M | -73.93%374.67M | -74.60%160.22M | -94.12%29.34M | -95.20%13.8M | 274.93%1.44B | 67.22%630.84M | 647.42%498.67M | 8,600.31%287.51M | -0.73%383.36M |
| Net cash flows from financing activities | 11.00%-12.28M | 72.14%-359.67M | 67.74%-160.22M | 91.95%-29.34M | 91.00%-13.8M | -241.02%-1.29B | -32.46%-496.64M | -446.28%-364.47M | -4,539.27%-153.31M | 1.96%-378.62M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 166.64%867.55K | -69.93%3.69M | -66.20%4.57M | -55.80%3.76M | 1.53%-1.3M | 843.45%12.28M | 273.60%13.52M | 172.18%8.5M | -182.23%-1.32M | 1,996.64%1.3M |
| Net increase in cash and cash equivalents | 200.42%335.23M | -19.35%588.38M | -52.63%183.76M | -144.32%-337.78M | -182.88%-333.82M | 85.26%729.55M | 492.78%387.92M | 134.65%762.1M | -151.13%-118.01M | -29.16%393.8M |
| Add:Begin period cash and cash equivalents | 22.50%3.2B | 38.70%2.61B | 38.70%2.61B | 38.70%2.61B | 38.71%2.61B | 26.42%1.89B | 26.41%1.89B | 26.41%1.89B | 26.41%1.89B | 59.43%1.49B |
| End period cash equivalent | 55.13%3.54B | 22.50%3.2B | 23.11%2.8B | -13.99%2.28B | 29.08%2.28B | 38.71%2.61B | 46.01%2.27B | 45.76%2.65B | 2.61%1.77B | 26.41%1.89B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg